Aratana Therapeutics (PETX) Inventory Turnover Ratio, from first quarter 2019 to first quarter 2018, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Aratana Therapeutics, Inc.  (PETX)
 

Aratana Therapeutics Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Aratana Therapeutics, Inc. inventory turnover ratio, the Aratana Therapeutics, Inc.'s ability to sell and replace its inventory in the first quarter 2019, sequentially increased to 0.61 in the first quarter 2019, yet the ratio remained below the average, as PETX's market remain challenging.Average inventory processing period, for the Aratana Therapeutics in Mar 31 2019 quarter, has decreased to 598 days, compare to 730 days, in the Dec 31 2018 quarter.

Within Healthcare sector 378 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 2067 in the fourth quarter 2018, to 2069.

PETX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Aratana Therapeutics, Inc. Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PETX Inventory Turnover Ratio (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Inventory Growth -22.39 % -15.84 % 51.89 % 118.3 % 54.08 %
Y / Y Cost of Sales Growth 183.4 % -53.15 % -41.14 % -64.64 % -82.68 %
Inventory Turnover Ratio (TTM) 0.61 0.5 0.7 0.88 1.27
PETX's Total Ranking # 2069 # 2067 # 2064 # 2046 # 2076
Average inventory processing period 601 731 519 413 287
Seq. Inventory Growth -5.23 % -16.8 % -9.63 % 8.92 % 2.77 %
Seq. Cost of Sales Growth -45.16 % 27.53 % 66.44 % 143.47 % -90.93 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 130
Healthcare Sector # 379
Overall Market # 2069

Inventory Turnover Ratio Statistics
High Average Low
2.03 0.94 0.19
(Sep 30 2014)   (Mar 31 2016)



PETX Company Profile >> Back to PETX Efficiency Comparisons >> Compare PETX Inventory Turnover Ratio to its Competitors

Financial Statements
Aratana Therapeutics's Inventories $ 11 Millions Visit PETX's Balance sheet
Aratana Therapeutics's Cost of Revenues TTM $ 8 Millions Visit PETX's Income Statement
What are PETX's Sales? Visit PETX's Sales by Segment

Other Inventory Turnover Ratios
Aratana Therapeutics's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PETX's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PETX's Competitors
Inventory Turnover Ratio for PETX's Suppliers
Inventory Turnover Ratio for PETX's Customers

You may also want to know
PETX's Sales Growth Rates PETX's Pe Price to earnings ratio PETX's Receivables Turnover Ratio PETX's Stock Quote
PETX's Net Income Growth Rates PETX's Ps Price to Sales ratio PETX's Sales per Employee PETX's Asset Turnover Ratio
PETX's Net Margin PETX's Pb Price to Book ratio PETX's Financial Strength Ratios PETX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2019, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2019 Inventories at quarter ending Mar 31 2019
Hologic Inc  1.96 $ 791.200  Millions$ 404  Millions
Glaukos Corp  1.95 $ 26.400  Millions$ 14  Millions
Orthofix Medical Inc   1.95 $ 96.235  Millions$ 49  Millions
Bruker Corporation  1.94 $ 1,010.900  Millions$ 520  Millions
Integra Lifesciences Holdings Corp  1.94 $ 556.186  Millions$ 287  Millions
Nektar Therapeutics  1.92 $ 23.206  Millions$ 12  Millions
Meridian Bioscience Inc   1.92 $ 81.549  Millions$ 42  Millions
Sunwin Stevia International Inc.  1.91 $ 23.696  Millions$ 12  Millions
Intersect Ent Inc   1.90 $ 21.776  Millions$ 11  Millions
Abiomed Inc   1.90 $ 129.567  Millions$ 68  Millions
Viewray Inc   1.87 $ 79.387  Millions$ 43  Millions
Decoy Therapeutics Inc   1.85 $ 0.394  Millions$ 0  Millions
The Cooper Companies Inc   1.84 $ 885.900  Millions$ 482  Millions
Avinger Inc   1.82 $ 6.583  Millions$ 4  Millions
China Pharma Holdings Inc  1.79 $ 10.067  Millions$ 6  Millions
Bio rad Laboratories Inc   1.79 $ 1,059.165  Millions$ 592  Millions
Iradimed Corporation  1.78 $ 7.568  Millions$ 4  Millions
Taro Pharmaceutical Industries Ltd  1.76 $ 224.169  Millions$ 127  Millions
Nuwellis Inc   1.75 $ 3.381  Millions$ 2  Millions
Invo Fertility Inc   1.75 $ 0.087  Millions$ 0  Millions
United Therapeutics Corporation  1.74 $ 174.600  Millions$ 100  Millions
Cormedix Inc   1.71 $ 0.798  Millions$ 0  Millions
Stryker Corp  1.68 $ 4,900.000  Millions$ 2,913  Millions
Thermogenesis Holdings Inc   1.68 $ 7.668  Millions$ 5  Millions
Ani Pharmaceuticals Inc  1.67 $ 67.056  Millions$ 40  Millions
Vivani Medical Inc   1.65 $ 4.951  Millions$ 3  Millions
Repligen Corp  1.65 $ 70.116  Millions$ 43  Millions
Nephros Inc   1.63 $ 2.737  Millions$ 2  Millions
Edwards Lifesciences Corporation  1.57 $ 937.600  Millions$ 597  Millions
Pressure Biosciences Inc   1.52 $ 1.265  Millions$ 1  Millions

Date modified: 2026-08-29T17:20:13+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.